![]() |
|||||
|
![]() | |
![]() | |
![]() | |
![]() | |
![]() | |
![]() | |
![]() |
Gene: CTU2 |
Gene summary for CTU2 |
![]() |
Gene information | Species | Human | Gene symbol | CTU2 | Gene ID | 348180 |
Gene name | cytosolic thiouridylase subunit 2 | |
Gene Alias | C16orf84 | |
Cytomap | 16q24.3 | |
Gene Type | protein-coding | GO ID | GO:0002097 | UniProtAcc | Q2VPK5 |
Top |
Malignant transformation analysis |
![]() |
![]() |
Entrez ID | Symbol | Replicates | Species | Organ | Tissue | Adj P-value | Log2FC | Malignancy |
348180 | CTU2 | LZE7T | Human | Esophagus | ESCC | 2.44e-06 | 2.21e-01 | 0.0667 |
348180 | CTU2 | LZE20T | Human | Esophagus | ESCC | 9.14e-04 | 1.41e-01 | 0.0662 |
348180 | CTU2 | LZE24T | Human | Esophagus | ESCC | 1.67e-09 | 2.01e-01 | 0.0596 |
348180 | CTU2 | P2T-E | Human | Esophagus | ESCC | 3.88e-10 | 2.03e-01 | 0.1177 |
348180 | CTU2 | P4T-E | Human | Esophagus | ESCC | 9.80e-06 | 1.90e-01 | 0.1323 |
348180 | CTU2 | P5T-E | Human | Esophagus | ESCC | 1.69e-10 | 1.61e-01 | 0.1327 |
348180 | CTU2 | P8T-E | Human | Esophagus | ESCC | 6.52e-16 | 2.20e-01 | 0.0889 |
348180 | CTU2 | P9T-E | Human | Esophagus | ESCC | 6.71e-05 | 1.37e-01 | 0.1131 |
348180 | CTU2 | P10T-E | Human | Esophagus | ESCC | 3.68e-12 | 2.43e-01 | 0.116 |
348180 | CTU2 | P11T-E | Human | Esophagus | ESCC | 2.76e-05 | 2.49e-01 | 0.1426 |
348180 | CTU2 | P12T-E | Human | Esophagus | ESCC | 2.01e-25 | 2.65e-01 | 0.1122 |
348180 | CTU2 | P15T-E | Human | Esophagus | ESCC | 2.14e-11 | 2.49e-01 | 0.1149 |
348180 | CTU2 | P16T-E | Human | Esophagus | ESCC | 1.05e-08 | 1.63e-01 | 0.1153 |
348180 | CTU2 | P17T-E | Human | Esophagus | ESCC | 5.21e-08 | 4.11e-01 | 0.1278 |
348180 | CTU2 | P19T-E | Human | Esophagus | ESCC | 3.08e-03 | 3.30e-01 | 0.1662 |
348180 | CTU2 | P20T-E | Human | Esophagus | ESCC | 4.95e-12 | 2.28e-01 | 0.1124 |
348180 | CTU2 | P21T-E | Human | Esophagus | ESCC | 1.89e-22 | 3.00e-01 | 0.1617 |
348180 | CTU2 | P22T-E | Human | Esophagus | ESCC | 1.26e-16 | 1.36e-01 | 0.1236 |
348180 | CTU2 | P23T-E | Human | Esophagus | ESCC | 3.36e-20 | 5.09e-01 | 0.108 |
348180 | CTU2 | P24T-E | Human | Esophagus | ESCC | 4.98e-14 | 1.62e-01 | 0.1287 |
Page: 1 2 3 4 |
![]() |
∗log2FC in expression of this searched gene in stem-like cells from each diseased tissue sample relative to stem-like cells in normal samples in each tissue plotted against the malignancy continuum. Samples are colored based on if they are from different disease stage. |
Top |
Malignant transformation related pathway analysis |
![]() |
![]() |
Tissue | Disease Stage | Enriched GO biological Processes |
Colorectum | AD | ![]() |
Colorectum | SER | ![]() |
Colorectum | MSS | ![]() |
Colorectum | MSI-H | ![]() |
Colorectum | FAP | ![]() |
∗Top 15 enriched GO BP terms are showed in the bar plot of each disease state in each tissue. Each row represents a significant GO biological process which is colored according to the -log10(p.adjust). |
Page: 1 2 3 4 5 6 7 8 9 |
![]() |
GO ID | Tissue | Disease Stage | Description | Gene Ratio | Bg Ratio | pvalue | p.adjust | Count |
GO:003447015 | Esophagus | ESCC | ncRNA processing | 300/8552 | 395/18723 | 3.09e-35 | 3.26e-32 | 300 |
GO:003466012 | Esophagus | ESCC | ncRNA metabolic process | 346/8552 | 485/18723 | 4.35e-31 | 2.51e-28 | 346 |
GO:00080333 | Esophagus | ESCC | tRNA processing | 92/8552 | 127/18723 | 7.83e-10 | 1.93e-08 | 92 |
GO:00063992 | Esophagus | ESCC | tRNA metabolic process | 122/8552 | 179/18723 | 9.03e-10 | 2.19e-08 | 122 |
GO:00094512 | Esophagus | ESCC | RNA modification | 114/8552 | 167/18723 | 2.76e-09 | 6.04e-08 | 114 |
GO:00064002 | Esophagus | ESCC | tRNA modification | 62/8552 | 90/18723 | 7.02e-06 | 7.04e-05 | 62 |
GO:00344709 | Oral cavity | OSCC | ncRNA processing | 263/7305 | 395/18723 | 4.38e-29 | 2.78e-26 | 263 |
GO:00346605 | Oral cavity | OSCC | ncRNA metabolic process | 296/7305 | 485/18723 | 2.94e-23 | 6.65e-21 | 296 |
GO:00080332 | Oral cavity | OSCC | tRNA processing | 78/7305 | 127/18723 | 2.56e-07 | 4.00e-06 | 78 |
GO:00063991 | Oral cavity | OSCC | tRNA metabolic process | 101/7305 | 179/18723 | 1.65e-06 | 2.15e-05 | 101 |
GO:00094511 | Oral cavity | OSCC | RNA modification | 95/7305 | 167/18723 | 2.05e-06 | 2.62e-05 | 95 |
GO:00064001 | Oral cavity | OSCC | tRNA modification | 53/7305 | 90/18723 | 1.04e-04 | 7.70e-04 | 53 |
Page: 1 |
![]() |
Pathway ID | Tissue | Disease Stage | Description | Gene Ratio | Bg Ratio | pvalue | p.adjust | qvalue | Count |
Page: 1 |
Top |
Cell-cell communication analysis |
![]() |
Ligand | Receptor | LRpair | Pathway | Tissue | Disease Stage |
Page: 1 |
Top |
Single-cell gene regulatory network inference analysis |
![]() |
TF | Cell Type | Tissue | Disease Stage | Target Gene | RSS | Regulon Activity |
∗The dot plots of a searched regulon are shown for all cell subpopulations in each disease state of each tissue based on the regulon specific score inferred using pySCENIC and by calculating the average expression. |
Page: 1 |
Top |
Somatic mutation of malignant transformation related genes |
![]() |
Hugo Symbol | Variant Class | Variant Classification | dbSNP RS | HGVSc | HGVSp | HGVSp Short | SWISSPROT | BIOTYPE | SIFT | PolyPhen | Tumor Sample Barcode | Tissue | Histology | Sex | Age | Stage | Therapy Types | Drugs | Outcome |
CTU2 | SNV | Missense_Mutation | rs766039051 | c.1408N>A | p.Ala470Thr | p.A470T | protein_coding | tolerated(0.88) | benign(0) | TCGA-F4-6856-01 | Colorectum | colon adenocarcinoma | Male | <65 | I/II | Ancillary | leucovorin | CR | |
CTU2 | SNV | Missense_Mutation | c.1626N>T | p.Lys542Asn | p.K542N | protein_coding | deleterious(0) | probably_damaging(0.943) | TCGA-A5-A0G1-01 | Endometrium | uterine corpus endometrioid carcinoma | Female | >=65 | I/II | Unknown | Unknown | SD | ||
CTU2 | SNV | Missense_Mutation | novel | c.1051N>A | p.Ala351Thr | p.A351T | protein_coding | deleterious(0) | possibly_damaging(0.896) | TCGA-A5-A1OF-01 | Endometrium | uterine corpus endometrioid carcinoma | Female | <65 | I/II | Unknown | Unknown | SD | |
CTU2 | SNV | Missense_Mutation | novel | c.731C>G | p.Ala244Gly | p.A244G | protein_coding | tolerated(0.14) | benign(0.037) | TCGA-AP-A051-01 | Endometrium | uterine corpus endometrioid carcinoma | Female | >=65 | I/II | Unknown | Unknown | SD | |
CTU2 | SNV | Missense_Mutation | novel | c.1529G>A | p.Gly510Asp | p.G510D | protein_coding | tolerated(0.05) | benign(0.116) | TCGA-AP-A1DK-01 | Endometrium | uterine corpus endometrioid carcinoma | Female | <65 | I/II | Unknown | Unknown | SD | |
CTU2 | SNV | Missense_Mutation | novel | c.1663C>A | p.Leu555Met | p.L555M | protein_coding | deleterious(0.01) | probably_damaging(0.98) | TCGA-AP-A1DK-01 | Endometrium | uterine corpus endometrioid carcinoma | Female | <65 | I/II | Unknown | Unknown | SD | |
CTU2 | SNV | Missense_Mutation | novel | c.776N>C | p.Leu259Pro | p.L259P | protein_coding | tolerated(0.32) | benign(0.046) | TCGA-AX-A2HD-01 | Endometrium | uterine corpus endometrioid carcinoma | Female | >=65 | III/IV | Unknown | Unknown | SD | |
CTU2 | SNV | Missense_Mutation | rs754271225 | c.314G>A | p.Arg105His | p.R105H | protein_coding | deleterious(0) | probably_damaging(0.999) | TCGA-B5-A0K9-01 | Endometrium | uterine corpus endometrioid carcinoma | Female | >=65 | I/II | Unknown | Unknown | SD | |
CTU2 | SNV | Missense_Mutation | novel | c.83N>A | p.Cys28Tyr | p.C28Y | protein_coding | deleterious(0) | probably_damaging(0.999) | TCGA-B5-A1MX-01 | Endometrium | uterine corpus endometrioid carcinoma | Female | <65 | I/II | Hormone Therapy | megace | SD | |
CTU2 | SNV | Missense_Mutation | rs773984513 | c.797N>A | p.Gly266Asp | p.G266D | protein_coding | tolerated(0.62) | benign(0.167) | TCGA-B5-A3FC-01 | Endometrium | uterine corpus endometrioid carcinoma | Female | <65 | I/II | Unknown | Unknown | SD |
Page: 1 2 3 4 5 |
Top |
Related drugs of malignant transformation related genes |
![]() |
(DGIdb 4.0) |
Entrez ID | Symbol | Category | Interaction Types | Drug Claim Name | Drug Name | PMIDs |
Page: 1 |